121 related articles for article (PubMed ID: 1372459)
1. [Significance of pathological alpha-1-fetoprotein levels in the framework of prenatal diagnosis].
Casper F; Möbus V; Wellek S; Gehm D; Seufert R; Brockerhoff P; Kreienberg R
Z Geburtshilfe Perinatol; 1992; 196(1):7-10. PubMed ID: 1372459
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
3. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
Zwahr C; Voss P; Kistner G
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
6. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
7. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
[TBL] [Abstract][Full Text] [Related]
8. [Alpha fetoprotein in maternal serum in pregnancies with trisomy 18].
Dix U; Gams M; Grubisic A; Dericks-Tan JS; Langenbeck U
Z Geburtshilfe Perinatol; 1988; 192(5):231-3. PubMed ID: 2463716
[TBL] [Abstract][Full Text] [Related]
9. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
10. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
11. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of structural abnormalities.
Sanders RC
Curr Opin Obstet Gynecol; 1991 Apr; 3(2):259-65. PubMed ID: 1717021
[TBL] [Abstract][Full Text] [Related]
13. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
[TBL] [Abstract][Full Text] [Related]
15. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
16. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
19. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
20. [Triple test: problem or enhancement of prenatal diagnosis].
Rauskolb R; Engel W
Z Geburtshilfe Neonatol; 1995; 199(3):91. PubMed ID: 7553260
[No Abstract] [Full Text] [Related]
[Next] [New Search]